
1. j clin microbiol. 2014 feb;52(2):578-86. doi: 10.1128/jcm.02860-13. epub 2013 dec
11.

field evaluation dried blood spots routine hiv-1 viral load drug
resistance monitoring patients receiving antiretroviral therapy africa 
asia.

monleau m(1), aghokeng af, eymard-duvernay s, dagnra a, kania d, ngo-giang-huong 
n, touré-kane c, truong lx, chaix ml, delaporte e, ayouba a, peeters m; anrs
12235 study group.

collaborators: ayouba a, aghokeng a, bazin b, brun-vézinet f, chaix ml, descamps 
d, fleury h, dramane k, nouhin j, kane ct, lien tx, masquelier b, monleau m,
ngo-giang-huong n, peeters m, plantier jc, rekacewicz c, d'aquin tt, granouillac 
b, sawadogo a, hema a, kaboré f, bado g, sombié d, guibla o, davou-traoré m,
gampini se, kagoné t, valea d, ouoba a, zango a, ouédraogo s, dahourou-bazié o,
kangoyé f, mpoudi-ngole e, chia je, edoul g, pouth e, nwahba e, onana b, diouf
nl, ndiaye hd, diouara aa, diassy ar, manga nm, diop in, ouatara b, dieng c,
diagne n, ndiaye m, bowonwattanuwong c, nilmanat a, lertkoonlak r,
buranabanjasatean s, sangargard p, kaewbundit a, sukrakanchana po, wangsaeng n,
mensah e, aho k, denke c, damarly k, ton t, thu hh, anh lq, quang pd, trung nv,
the le v, phuong bt.

author information: 
(1)umi 233 transvihmi, ird, université de montpellier 1, montpellier, france.

comment in
    j clin microbiol. 2014 jul;52(7):2740-1.

dried blood spots (dbs) used developing countries alleviate the
logistic constraints using blood plasma specimens viral load (vl) hiv 
drug resistance (hivdr) testing, assessed field
conditions. 2009 2011, collected paired plasma-dbs samples from
treatment-experienced hiv-1-infected adults burkina faso, cameroon, senegal,
togo, thailand, vietnam. dbs stored ambient temperature 2 
to 4 weeks subsequently -20°c testing. vl testing performed 
the plasma samples dbs using locally available methods: abbott m2000rt
hiv-1 test, generic g2 real-time pcr, nuclisens easyq version 1.2 test. in
the case virological failure (vf), i.e., plasma vl ≥1,000 copies/ml,
hivdr genotyping performed paired plasma-dbs samples. overall, compared
382 plasma-dbs sample pairs dbs vl testing accuracy. sensitivities the
different assays different laboratories detecting vf using dbs varied from
75% 100% m2000rt test labs b, c, d, 91% 93% generic g2
real-time pcr labs f, 85% nuclisens test lab e. the
specificities varied 82% 97% m2000rt nuclisens tests and
reached 60% generic g2 test. nuclisens test showed good
agreement plasma dbs vl underestimated dbs vl. lowest
agreement observed generic g2 test. genotyping successful for
96/124 (77%) dbs tested, 75/96 (78%) plasma-dbs pairs identical hivdr
mutations. significant discrepancies resistance interpretations observed 
in 9 cases, 6 laboratory. dbs successfully
used alternative blood plasma samples routine vl hivdr
monitoring african asian settings. however, selection adequate
vl measurement method definition vf threshold be
considered, laboratory performance monitored.

doi: 10.1128/jcm.02860-13 
pmcid: pmc3911301
pmid: 24478491  [indexed medline]

